Hims & Hers Health (NYSE:HIMS – Free Report) had its price objective hoisted by Canaccord Genuity Group from $20.00 to $24.00 in a research report sent to investors on Wednesday, Benzinga reports. The brokerage currently has a buy rating on the stock. HIMS has been the topic of several other research reports. Leerink Partnrs reiterated […]
Citigroup downgraded shares of Hims & Hers Health (NYSE:HIMS – Free Report) from a buy rating to a neutral rating in a report published on Wednesday, MarketBeat.com reports. Citigroup currently has $20.00 price target on the stock, up from their previous price target of $16.00. Several other equities analysts have also issued reports on HIMS. […]
Mckinley Capital Management LLC lifted its position in shares of Hims & Hers Health, Inc. (NYSE:HIMS – Free Report) by 34.9% during the 4th quarter, HoldingsChannel.com reports. The fund owned 896,020 shares of the company’s stock after acquiring an additional 231,867 shares during the quarter. Hims & Hers Health makes up about 1.0% of Mckinley […]
Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) insider Irene Becklund sold 943 shares of the stock in a transaction that occurred on Friday, May 17th. The shares were sold at an average price of $14.50, for a total value of $13,673.50. The transaction was disclosed in a document filed with the Securities […]
Hims & Hers Health (NYSE:HIMS) Shares Gap Up on Earnings Beat themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.